Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
PF-03049423
DRUG
2 trials
Sponsors
Pfizer
Conditions
Healthy
Ischemic Stroke
Phase 1
A Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03049423 In Healthy Adult Volunteers And Healthy Older Volunteers
Completed
NCT01161069
Pfizer
Healthy
Start: 2009-08-31
End: 2009-12-31
Updated: 2011-08-09
Phase 2
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
Terminated
NCT01208233
Pfizer
Ischemic Stroke
Start: 2010-12-31
End: 2013-12-31
Updated: 2016-02-19
Related Papers
Phosphodiesterase-5 Inhibitor PF-03049423 Effect on Stroke Recovery: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.
2015-12-28
11 citations